270 related articles for article (PubMed ID: 16687097)
1. Evolving concepts in the management of lobular neoplasia.
Anderson BO; Calhoun KE; Rosen EL
J Natl Compr Canc Netw; 2006 May; 4(5):511-22. PubMed ID: 16687097
[TBL] [Abstract][Full Text] [Related]
2. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
3. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.
Shin SJ; Rosen PP
Arch Pathol Lab Med; 2002 Jun; 126(6):697-701. PubMed ID: 12033958
[TBL] [Abstract][Full Text] [Related]
4. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature.
Cangiarella J; Guth A; Axelrod D; Darvishian F; Singh B; Simsir A; Roses D; Mercado C
Arch Pathol Lab Med; 2008 Jun; 132(6):979-83. PubMed ID: 18517282
[TBL] [Abstract][Full Text] [Related]
5. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
Berg WA; Mrose HE; Ioffe OB
Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
[TBL] [Abstract][Full Text] [Related]
6. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
7. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
8. How Do We Approach Benign Proliferative Lesions?
Nakhlis F
Curr Oncol Rep; 2018 Mar; 20(4):34. PubMed ID: 29572753
[TBL] [Abstract][Full Text] [Related]
9. Management of Lobular Neoplasia Diagnosed by Core Biopsy.
Jani C; Lotz M; Keates S; Gupta Y; Walker A; Al Omari O; Parvez A; Patel D; Gnata M; Perry J; Khorashadi L; Weissmann L; Pories SE
Breast J; 2023; 2023():8185446. PubMed ID: 37114120
[TBL] [Abstract][Full Text] [Related]
10. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for women with lobular carcinoma in situ (LCIS).
Oppong BA; King TA
Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
[TBL] [Abstract][Full Text] [Related]
12. Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.
Lewin AA; Mercado CL
AJR Am J Roentgenol; 2020 Feb; 214(2):265-275. PubMed ID: 31825261
[No Abstract] [Full Text] [Related]
13. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?
Ibrahim N; Bessissow A; Lalonde L; Mesurolle B; Trop I; Lisbona A; El-Khoury M
AJR Am J Roentgenol; 2012 Feb; 198(2):288-91. PubMed ID: 22268170
[TBL] [Abstract][Full Text] [Related]
14. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
[TBL] [Abstract][Full Text] [Related]
15. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
16. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.
Genco IS; Tugertimur B; Chang Q; Cassell L; Hajiyeva S
Virchows Arch; 2020 Feb; 476(2):209-217. PubMed ID: 31776645
[TBL] [Abstract][Full Text] [Related]
18. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy.
Irfan K; Brem RF
Breast J; 2002; 8(4):230-3. PubMed ID: 12100116
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases.
O'Neil M; Madan R; Tawfik OW; Thomas PA; Fan F
Ann Diagn Pathol; 2010 Aug; 14(4):251-5. PubMed ID: 20637429
[TBL] [Abstract][Full Text] [Related]
20. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
Lewis JL; Lee DY; Tartter PI
Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
